AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-9173824_ITM" title="Facts and information about Cantab bought by Xenova.">Cantab bought by Xenova.</a>

Close Set up an RSS feed that alerts you when new articles from Corporate Money are available.

Frequently asked questions about RSS feeds

Cantab bought by Xenova.

Corporate Money

| February 21, 2001 | COPYRIGHT 1999 Centaur Communications Limited. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Cantab Pharmaceuticals, a UK vaccine developer, said it will sell itself to Slough-based biotechnology company Xenova Group. The deal comes four months after Cantab put itself up for sale following the 67% one-day drop in its shareprice last October.

Nick Hart, acting CEO of Cantab said: "The enlarged group brings together two companies with a joint focus on cancer and complementary technologies in drug discovery, providing a foundation for the development of innovative medicines with high commercial potential."

Xenova will offer 11 new shares for every seven Cantab shares. It values each Cantab share at approximately l4Op, representing a premium of 16.5% on…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Cantab Pharmaceuticals Reports Fourth Quarter Results: Press release article from: PR Newswire March 19, 1997 700+ words
...England, March 19 /PRNewswire/ -- Cantab Pharmaceuticals plc (Nasdaq: CNTBY...additional 115,000 pounds received under Cantab's existing research agreement with Pfizer Animal Healthcare Group. In 1995, Cantab's revenues came mainly from the Pfizer...


CANTAB PHARMACEUTICALS REPORTS FIRST QUARTER RESULTS: Press release article from: PR Newswire May 14, 1996 700+ words
...England, May 14 /PRNewswire/ -- Cantab Pharmaceuticals plc (Nasdaq: CNTBY...first quarter of 1996 were earned under Cantab's collaborative agreement with Pfizer...first quarter of 1995 were related to Cantab's agreement with Baxter Healthcare...


Cantab Pharmaceuticals Reports Second Quarter Results: Press release article from: PR Newswire August 12, 1996 700+ words
...England, Aug. 12 /PRNewswire/ -- Cantab Pharmaceuticals plc (Nasdaq: CNTBY...contract development fees earned under Cantab's current collaborative agreement with...contract development fees earned under Cantab's collaborative agreement with Baxter...


CANTAB PHARMACEUTICALS AND CANCER RESEARCH CAMPAIGN TECHNOLOGY SIGN NEW...: Press release article from: PR Newswire July 19, 1993 700+ words
...U.K., July 19 /PRNewswire/ -- Cantab Pharmaceuticals plc (NASDAQ: CNTBY...their recurrence. The agreement gives Cantab an option to acquire exclusive worldwide...president and chief executive officer of Cantab. "We believe that our immunotherapeutic...


CANTAB AND PFIZER FORGE ALLIANCE IN VIRAL VACCINES: Press release article from: PR Newswire September 21, 1995 700+ words
...NEW YORK, Sept. 21 /PRNewswire/ -- Cantab Pharmaceuticals plc (Nasdaq: CNTBY...alliance for animal health applications of Cantab's DISC-VIRUS(TM) vaccine technology...and an equity investment. In addition, Cantab estimates that it could receive another...


CANTAB PHARMACEUTICALS REPORTS THIRD QUARTER RESULTS: Press release article from: PR Newswire November 29, 1993 700+ words
...England, Nov. 29 /PRNewswire/ -- Cantab Pharmaceuticals plc (NASDAQ: CNTBY...Corporation (NYSE: BAX) relating to Cantab's LM-CD45 product development program...reflects continued investment in advancing Cantab's portfolio of product development programs...


CANTAB PHARMACEUTICALS INTENDS TO RAISE 25 MILLION POUNDS STERLING IN SECONDARY...: Press release article from: PR Newswire May 14, 1996 700+ words
...England, May 14 /PRNewswire/ -- Cantab Pharmaceuticals plc (Nasdaq: CNTBY...of a non pre-emptive Offering of new Cantab Common Shares to be listed on the London...States. The Offering will be subject to Cantab Shareholder approval to disapply pre...


CANTAB PHARMACEUTICALS SIGNS AGREEMENT WITH OXFORD UNIVERSITY AND REPORTS ON...: Press release article from: PR Newswire May 4, 1993 700+ words
...CAMBRIDGE, England, May 4 /PRNewswire/ -- Cantab Pharmaceuticals plc (NASDAQ: CNTBY...University of Oxford. The agreement gives Cantab an option to acquire rights to certain...T-cell receptors for human therapy. Cantab's scientists will assist with the identification...


Cantab Pharmaceuticals Reports Third Quarter Results: Press release article from: PR Newswire November 29, 1996 700+ words
...England, Nov. 29 /PRNewswire/ -- Cantab Pharmaceuticals plc (Nasdaq: CNTBY...to begin its TA-GW collaboration with Cantab in July 1996, plus 65,000 pounds in...contract development fees earned under Cantab's collaborative agreement, ended in...


CANTAB AND SMITHKLINE BEECHAM FORM VACCINE COLLABORATION: Press release article from: PR Newswire July 18, 1996 700+ words
...Belgium, July 18 /PRNewswire/ -- Cantab Pharmaceuticals plc (Nasdaq: CNTBY...a collaboration to develop and market Cantab's TA-GW vaccine for genital warts. Under the financial terms of the agreement, Cantab can potentially receive Pound Sterling...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: